The Michelson Prizes are scientific awards of $150,000 given annually to young investigators who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research across major global diseases.
The 2020 Michelson Prizes will focus on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery. We will be looking for high-impact and highly innovative research that has the potential to be applied across many diseases and to significantly expand our understanding of the human immune system.
The initial application window for the 2020 Michelson Prizes is now closed. Applicants selected to submit a full application will be notified in late December 2019 and winners will be announced in April/May 2020. Prizes will be awarded in June 2020 as part of an annual scientific conference on the future of vaccine and immunotherapy development, which brings together top scientists from across disciplines and disease areas.
Ansuman Satpathy, M.D., Ph.D., Stanford University
A rigorous and competitive international search will identify the most innovative projects from young scientists working across a broad range of scientific fields. Proposals will be reviewed by a distinguished committee of internationally-recognized scientists. The review committee will be looking for research that challenges dogma, from researchers who clearly articulate a vision that demonstrates an ability to look beyond convention to make a lasting impact on vaccine and immunotherapy research. We encourage applications from the full spectrum of scientific disciplines related to immunology, vaccine, and immunotherapy research, including but not limited to:
Register to be emailed when the application portal opens:
The initial application window for the 2020 Michelson Prizes is now closed. The Michelson Prizes are open to early-career researchers under 35 at the time of application, and will focus on human immunology, vaccine discovery and immunotherapy research.
Dr. Gary K. Michelson is a Board Certified Orthopedic Spinal Surgeon, with more than 900 issued patents worldwide. His work has revolutionized the practice of spinal surgery, making such procedures less invasive, less traumatic, safer, faster, and more effective. Alya Michelson is an accomplished journalist, who has written in, and been published in four different languages.
Together they support a broad array of philanthropic endeavors and operate three foundations that they founded and fund; including a medical research foundation, an education foundation, and an animal welfare foundation. Further information is available at michelsonmedical.org, 20MM.